Chen Pin-Chun, Huang Hsin-Chung, Jeng Mei-Jy, Cheng Feng-Shiang
Department of Pharmacy, Taipei City Hospital, Taipei City, Taiwan.
Institute of Emergency and Critical Care Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei City, Taiwan.
Pediatr Gastroenterol Hepatol Nutr. 2024 Jul;27(4):246-257. doi: 10.5223/pghn.2024.27.4.246. Epub 2024 Jul 8.
Administering early parenteral amino acids to very low birth weight (VLBW) premature infants (birth body weight [BBW]<1,500 g) is challenging due to factors such as holidays, cost, and access to sterile compounding facilities. Using advance-prepared parenteral nutrition (PN) may address this issue and should be evaluated for its safety and potential benefits.
We extracted data from medical records collected between July 2015 and August 2019. VLBW infants received PN for at least seven days and were split into two groups: the traditional group (n=30), which initially received a glucose solution and then PN on workdays, and the pre-preparation group (n=16), which received advance-prepared PN immediately upon admission to the neonatal intensive care unit.
The median BBWs of the traditional and pre-preparation groups were 1,180.0 vs. 1,210.0 g. In the initial two days, the pre-preparation group had a significantly higher amino acid intake (2.23 and 2.24 g/kg/d) than the traditional group (0 and 1.78 g/kg/d). The pre-preparation group exhibited greater head circumference growth ratio relative to birth (7th day: 1.21% vs. -3.57%, =0.014; 21st day: 7.71% vs. 3.31%, =0.017). No significant differences in metabolic tolerance were observed.
Advanced preparation of PN can be safely implemented in VLBW preterm infants, offering advantages such as early, higher amino acid intake and improved head circumference growth within the first 21 days post-birth. This strategy may serve as a viable alternative in settings where immediate provision of sterile compounding facilities is challenging.
由于节假日、成本以及无菌配制设施的可及性等因素,对极低出生体重(VLBW)早产儿(出生体重[BBW]<1500g)早期给予肠外氨基酸具有挑战性。使用预先配制的肠外营养(PN)可能解决这一问题,应对其安全性和潜在益处进行评估。
我们从2015年7月至2019年8月收集的病历中提取数据。VLBW婴儿接受PN至少7天,并分为两组:传统组(n=30),最初接受葡萄糖溶液,然后在工作日接受PN;预配制组(n=16),在新生儿重症监护病房入院后立即接受预先配制的PN。
传统组和预配制组的中位BBW分别为1180.0g和1210.0g。在最初两天,预配制组的氨基酸摄入量(2.23和2.24g/kg/d)显著高于传统组(0和1.78g/kg/d)。预配制组相对于出生时的头围生长率更高(第7天:1.21%对-3.57%,P=0.014;第21天:7.71%对3.31%,P=0.017)。未观察到代谢耐受性的显著差异。
PN的预先配制可在VLBW早产儿中安全实施,具有诸如早期、更高的氨基酸摄入量以及出生后21天内头围生长改善等优势。在立即提供无菌配制设施具有挑战性的情况下,该策略可能是一种可行的替代方案。